Doesjka A Hagenaar, Karen G C B Bindels-de Heus, Maud M van Gils, Louise van den Berg, Leontine W Ten Hoopen, Philine Affourtit, Johan J M Pel, Koen F M Joosten, Manon H J Hillegers, Henriëtte A Moll, Marie-Claire Y de Wit, Gwen C Dieleman, Sabine E Mous
BACKGROUND: Angelman syndrome (AS) is a rare neurodevelopmental disorder characterized by severe intellectual disability, little to no expressive speech, visual and motor problems, emotional/behavioral challenges, and a tendency towards hyperphagia and weight gain. The characteristics of AS make it difficult to measure these children's functioning with standard clinical tests. Feasible outcome measures are needed to measure current functioning and change over time, in clinical practice and clinical trials...
March 1, 2024: Journal of Neurodevelopmental Disorders